Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Joubert Syndrome is a rare genetic disorder with an estimated prevalence ranging from 1 in 80,000 to 1 in 100,000 individuals worldwide. Because symptoms vary significantly and many cases may go undiagnosed, these figures are considered estimates rather than precise epidemiological counts. Is Joubert Syndrome considered rare? Yes, Joubert Syndrome is classified as a rare disease.
1 people with Joubert Syndrome have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Joubert Syndrome?
Prevalence of Joubert Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
TL;DR: Joubert Syndrome is a rare genetic disorder with an estimated prevalence ranging from 1 in 80,000 to 1 in 100,000 individuals worldwide. Because symptoms vary significantly and many cases may go undiagnosed, these figures are considered estimates rather than precise epidemiological counts.
Is Joubert Syndrome considered rare?
Yes, Joubert Syndrome is classified as a rare disease. While exact global numbers are difficult to ascertain, it is recognized as an ultra-rare to rare condition in most clinical literature. At DiseaseMaps.org, 82 people with Joubert Syndrome have joined our community, providing a vital real-world perspective on the daily challenges faced by those living with this spectrum of developmental disorders.
How does Joubert Syndrome affect different populations?
Joubert Syndrome does not show a significant preference for gender, affecting males and females with equal frequency. While it has been identified in individuals of all ethnic and geographic backgrounds, certain regions with higher rates of consanguinity (marriages between close relatives) may report higher localized clusters of the condition. Because Joubert Syndrome is primarily a genetic disorder, it is typically identified in infancy or early childhood, though milder forms may not be diagnosed until later in life.
What are the challenges in tracking prevalence?
Accurately mapping the prevalence of Joubert Syndrome is complicated by several factors:
- Clinical Heterogeneity: The condition presents as a spectrum, meaning individuals with milder symptoms may never seek a formal genetic diagnosis.
- Diagnostic Limitations: Access to advanced neuroimaging (like the "molar tooth sign" on MRI) and comprehensive genetic testing is not uniform globally.
- Misdiagnosis: Early symptoms, such as developmental delays or hypotonia, are often attributed to other neurological conditions, leading to under-reporting in medical databases.
Next steps
- Consult a clinical geneticist to discuss molecular testing and family screening for Joubert Syndrome.
- Connect with the 82 members at DiseaseMaps.org to share experiences and find peer support.
- Monitor the NIH GARD (Genetic and Rare Diseases Information Center) website for updates on clinical research and emerging registries.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Joubert Syndrome Overview
- Orphanet: Prevalence of rare diseases and Joubert Syndrome (ORPHA: 471)
- OMIM (Online Mendelian Inheritance in Man): Entry #213300
- Joubert Syndrome Foundation: Patient advocacy and community resources
Posted Aug 3, 2017 by Evelin 2000
